Skip to main content
. 2026 Sep 15;18(18):2979. doi: 10.3390/cancers18182979
ctDNA Circulating tumor deoxyribonucleic acid
CDK4/6 Cyclin-dependent kinases 4 and 6
DNA Deoxyribonucleic acid
ESR1 Estrogen receptor 1
HER2 Human epidermal growth factor receptor 2
HR Hormone receptor
MBC Metastatic breast cancer
MTD Maximum tolerated dose
OS Overall survival
PFS Progression-free survival
PIK3 Phosphoinositide 3 kinase
RB1 Retinoblastoma 1
TNBC Triple-negative breast cancer